On 14th May, 2020, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos convened a briefing in advance of the virtual 73rd session of the World Health Assembly.

The session was moderated by Ellen ‘t Hoen, LLM, PhD, Director, Medicines Law & Policy; MPP’s founding Executive Director, and included interventions from the following panelists:

  • Dr Mariângela Simão, Assistant Director-General Access to Medicines and Health Products, World Health Organization
  • Dr. Daniel Salas Peraza, Minister of Health, Costa Rica
  • Roman Macaya, MBA, PhD, Executive President of the Board of Directors of the Costa Rican Social Security Fund
  • Dr Philippe Duneton, Executive Director a.i., Unitaid
  • James Love, Director, Knowledge Ecology International (KEI)
  • Dr Marie-Paule Kieny, Director of research, Inserm, France; Chair of the Board, Drugs for Neglected Diseases Initiative (DNDi) and Medicines Patent Pool
  • Dr. Carlos María Correa, Executive Director, South Centre
  • Paul Fehlner, PhD, President & CEO, reVision Therapeutics, Inc
  • Charles Gore, Executive Director, Medicines Patent Pool
  • Bernard Pecoul, Executive Director, Drugs for Neglected Diseases initiative (DNDi)